Shiga Toxin–Producing Escherichia coli and the Hemolytic–Uremic Syndrome
Authors:
- Stephen B FreedmanStephen B Freedman
- Nicole C A J van de KarNicole C A J van de Kar
- Phillip I TarrPTPhillip I Tarr
- 12 October 2023
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 389 (15) , 1402-1414
Abstract
No abstract availableThis publication has 92 references indexed in Scilit:
- Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic SyndromeNew England Journal of Medicine, 2013
- Risk Factors for Development of Hemolytic Uremic Syndrome in a Cohort of Adult Patients with STEC 0104:H4 InfectionPLOS ONE, 2013
- An Epidemiologic Surveillance of Shiga-like Toxin-producing Escherichia coli Infection in Argentinean ChildrenThe Pediatric Infectious Disease Journal, 2012
- Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli–induced hemolytic uremic syndromeBlood, 2011
- Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndromePediatric Nephrology, 2008
- Relative Nephroprotection DuringEscherichia coliO157:H7 Infections: Association With Intravenous Volume ExpansionPediatrics, 2005
- Platelet-activating factor and Escherichia coli O157:H7 infectionsPediatric Nephrology, 2002
- Escherichia coliO157:H7 Infections: Discordance between Filterable Fecal Shiga Toxin and Disease OutcomeThe Journal of Infectious Diseases, 2002
- Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndromeThe Journal of Pediatrics, 1990
- SPORADIC CASES OF HAEMOLYTIC-URAEMIC SYNDROME ASSOCIATED WITH FAECAL CYTOTOXIN AND CYTOTOXIN-PRODUCING ESCHERICHIA COLI IN STOOLSThe Lancet, 1983